Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2)

Harmen R. Moes*, Erik Buskens, Teus van Laar

*Corresponding author for this work

Research output: Contribution to journalErratum

6 Downloads (Pure)

Abstract

Following publication of the original article [1], the authors reported that the reference details to Antonini et al., 2024 (the other commentary in Matters Arising) are not correct. The correct details of the reference should be “Antonini A., Chaudhuri K.R., Domingos J., Jimenez-Shahed J., Wright J., Yan C.H., Alobaidi A., Bergmann L., Onuk K., Harmer L. and Malaty I. A. Response to letter to the editor regarding “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”. BMC Neurology. 2024. https://doi.org/10.1186/s12883-024-03691-3”. The original article [1] has been updated.

Original languageEnglish
Article number240
Number of pages1
JournalBMC NEUROLOGY
Volume24
DOIs
Publication statusPublished - 10-Jul-2024

Fingerprint

Dive into the research topics of 'Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2)'. Together they form a unique fingerprint.

Cite this